KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolent Health (EVH) Revenue (2016 - 2025)

Evolent Health has reported Revenue over the past 11 years, most recently at $468.7 million for Q4 2025.

  • Quarterly results put Revenue at $468.7 million for Q4 2025, down 27.5% from a year ago — trailing twelve months through Dec 2025 was $1.9 billion (down 26.56% YoY), and the annual figure for FY2025 was $1.9 billion, down 26.56%.
  • Revenue for Q4 2025 was $468.7 million at Evolent Health, down from $479.5 million in the prior quarter.
  • Over the last five years, Revenue for EVH hit a ceiling of $647.1 million in Q2 2024 and a floor of $215.1 million in Q1 2021.
  • Median Revenue over the past 5 years was $456.5 million (2025), compared with a mean of $432.7 million.
  • Biggest five-year swings in Revenue: skyrocketed 58.49% in 2022 and later plummeted 31.34% in 2025.
  • Evolent Health's Revenue stood at $248.4 million in 2021, then skyrocketed by 53.98% to $382.4 million in 2022, then surged by 45.4% to $556.1 million in 2023, then grew by 16.27% to $646.5 million in 2024, then dropped by 27.5% to $468.7 million in 2025.
  • The last three reported values for Revenue were $468.7 million (Q4 2025), $479.5 million (Q3 2025), and $444.3 million (Q2 2025) per Business Quant data.